Activation of Akt2 Inhibits anoikis and apoptosis induced by myogenic differentiation

Y Fujio1, Y Mitsuuchi, J R Testa

  • 1Division of Cardiovascular Research, St. Elizabeth's Medical Center, Boston, MA 02135, USA.

Insights

Akt2 (a protein kinase) promotes cell survival during differentiation. Upregulated Akt2 confers resistance to apoptosis, suggesting a role in cancer development.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Akt1's anti-apoptotic role is known, but Akt2's function in cell survival is unclear.
  • Akt2 is amplified in ovarian and pancreatic cancers, hinting at its oncogenic potential.

Purpose of the Study:

  • To investigate the role of Akt2 in cellular survival during differentiation.
  • To determine if Akt2 confers resistance to apoptosis.

Main Methods:

  • Studied Akt2 expression (mRNA, protein, kinase activity) during C2C12 cell differentiation.
  • Used transient transfection and adenovirus-mediated gene transfer to manipulate Akt2 activity.
  • Assessed apoptosis resistance under various conditions, including serum deprivation and cell detachment.

Main Results:

  • Akt2 expression and activity increased during serum deprivation-induced myogenic differentiation.
  • Overexpression of wild-type and constitutively-active Akt2 protected differentiating cells from apoptosis.
  • Kinase-inactive Akt2 did not confer apoptosis resistance.
  • Akt2 protected cells from apoptosis induced by cell detachment.

Conclusions:

  • Akt2 acts as an anti-apoptotic gene during cellular differentiation.
  • Its anti-apoptotic function may contribute to its oncogenic properties in cancer.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...